– The US government continues to reconstruct its tariff wall with the launch of a Section 301 review of Germany’s drug prices, even though Germany has been paying more 256.8% more for imports of pharmaceuticals from the US since 2021.
– Tariffs are not the only form of restrictive trade policy that supply chain decision-makers have to navigate. The extension of mainland China’s rare earth restrictions to include to US firms is just the latest development in the country’s control over critical minerals. In the other direction, the US Commerce Department has questioned...